Free Practice Quiz Question List

2 Medications for Diabetes Beyond Insulin Online Quiz Questions

Use this free practice quiz with 20 questions to review 2 Medications for Diabetes Beyond Insulin, test your knowledge, and prepare for your next test or exam.

20 questions

Choose one

1 point

A person with type 2 diabetes who takes metformin has an eGFR of 28 mL/min/1.73 m². Which point is most important to discuss with the prescriber?

A
Contact the prescriber promptly because metformin is contraindicated below an eGFR of 30 mL/min/1.73 m².
B
Continue metformin because it causes severe hypoglycemia when used alone.
C
Continue metformin because it increases glucose excretion in the urine.
D
Add a sulfonylurea because metformin must always be combined with one.

Choose one

1 point

A person taking glipizide plans to skip breakfast. Which explanation best describes why this could increase the risk of low blood glucose?

A
Glipizide only works when glucose is excreted in the urine.
B
Glipizide stimulates insulin release, which can lower glucose even if breakfast is missed.
C
Glipizide slows carbohydrate absorption in the intestine.
D
Glipizide replaces insulin that the pancreas cannot make.

Choose one

1 point

A patient asks how an SGLT2 inhibitor such as empagliflozin lowers blood glucose. Which mechanism should you explain?

A
They slow the breakdown of incretin hormones.
B
They stimulate pancreatic beta cells to release insulin.
C
They reduce kidney reabsorption of glucose, increasing glucose excretion in urine.
D
They slow digestion and absorption of carbohydrates in the intestine.

Choose all

1 point

Select all medicine classes that may be recommended for health benefits for many people with type 2 diabetes and heart failure, chronic kidney disease, or cardiovascular disease, even when additional glucose lowering is not needed.

A
An SGLT2 inhibitor
B
A sulfonylurea
C
A GLP-1–based medicine
D
An alpha-glucosidase inhibitor

Choose all

1 point

A patient starting an SGLT2 inhibitor asks about possible safety concerns. Select all risks identified for this medicine class.

A
Genital yeast infections
B
Ketoacidosis that can occur without markedly elevated blood glucose
C
Severe hypoglycemia as an inevitable effect when used alone
D
Volume depletion

True or false

1 point

True or false: GLP-1–based medicines are used to treat type 1 diabetes.

A
True
B
False

True or false

1 point

True or false: If hypoglycemia occurs while taking acarbose with another glucose-lowering medicine, table sugar is recommended over glucose for raising blood glucose promptly.

A
True
B
False

Written response

1 point

Which medicine class stimulates short-acting insulin release around mealtimes?

Written response

1 point

Which vitamin deficiency can long-term metformin use contribute to?

Fill in the blank

1 point

Pioglitazone is a thiazolidinedione. This medicine class can cause and .

Fill in the blank

1 point

Take acarbose with the of the meal as directed. If hypoglycemia occurs while taking it with another glucose-lowering medicine, use rather than table sugar.

Open ended

1 point

Explain why selecting a non-insulin diabetes medicine requires considering more than its ability to lower blood glucose. Identify at least three patient-specific factors that can guide the choice.

Choose one

1 point

According to semaglutide prescribing information, which history is a reason not to use the medicine?

A
A personal or family history of medullary thyroid carcinoma
B
Seasonal allergies
C
Controlled hypertension
D
Prior use of metformin

Written response

1 point

Below what eGFR value, in mL/min/1.73 m², is metformin contraindicated?

Choose one

1 point

A person newly taking metformin has mild gastrointestinal effects and asks what commonly helps. Which response is best?

A
Increase the dose gradually and take it with food, as directed.
B
Add a DPP-4 inhibitor because the combination is required to prevent nausea.
C
Take each dose on an empty stomach to reduce gastrointestinal effects.
D
Stop the medicine permanently because gastrointestinal effects cannot improve.

Choose one

1 point

A patient taking a DPP-4 inhibitor is prescribed a GLP-1–based medicine. Which point about using both medicines together is most accurate?

A
The combination is generally recommended because it greatly increases glucose lowering.
B
The combination is generally not used because it adds little glucose-lowering benefit.
C
The combination is necessary to prevent kidney complications.
D
The combination is required to avoid gastrointestinal effects.

Choose one

1 point

A person who uses mealtime insulin asks whether pramlintide can replace their insulin. Which response is most accurate?

A
It replaces mealtime insulin because it raises insulin sensitivity.
B
It is used only to prevent kidney complications and is taken instead of other medicines.
C
It may be added to mealtime insulin for some people, but it does not replace insulin.
D
It is an oral medicine that stimulates the pancreas to release insulin at meals.

Choose one

1 point

A patient considering sitagliptin is concerned about weight gain and low blood glucose, and their kidney function is being reviewed. Which summary best addresses these concerns?

A
DPP-4 inhibitors are usually weight-neutral and have low hypoglycemia risk when used alone, though some need kidney-based dose adjustment.
B
DPP-4 inhibitors usually cause substantial weight gain and frequent hypoglycemia when used alone.
C
DPP-4 inhibitors always require the same dose regardless of kidney function.
D
DPP-4 inhibitors work by slowing carbohydrate absorption in the intestine.

True or false

1 point

True or false: When a patient starts a GLP-1–based medicine, gradual dose escalation is often used because gastrointestinal effects can occur.

A
True
B
False

Written response

1 point

Which medication class slows the breakdown of incretin hormones, thereby supporting glucose-dependent insulin release and reducing glucagon?

2 Medications for Diabetes Beyond Insulin Online Quiz Questions

Related study packs and tools